Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone

Treatment with rituximab plus a regimen of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) for patients with diffuse large B-cell lymphoma (DLBCL) has proven efficacy in clinical trials. The present study investigated its application in clinical practice. This single-center, retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Horvat, Matej, Zadnik, Vesna, Južnič Šetina, Tanja, Boltežar, Lučka, Pahole Goličnik, Jana, Novaković, Srdjan, Jezeršek Novaković, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796369/
https://www.ncbi.nlm.nih.gov/pubmed/29467881
http://dx.doi.org/10.3892/ol.2018.7774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796369/
https://www.ncbi.nlm.nih.gov/pubmed/29467881
http://dx.doi.org/10.3892/ol.2018.7774

Ejemplares similares